Subscribe
Sign In
Tag: CBT > Aurora Cannabis Canada: Page 2
Cannabis Industry Research
Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Cultivation
The research breakthroughs are poised to transform cannabis cultivation in high-latitude regions, opening new doors for advanced breeding strategies.
September 17, 2024
Cannabis Business Financial Report
Aurora Cannabis Announces Fiscal 2025 First Quarter Results and Delivers Positive Free Cash Flow
The Canadian company notes positive free cash flow of $6.5 million, record net revenue of $47.2 million in global medical cannabis and an end to the fiscal quarter debt-free with a cash position of approximately $182 million.
August 7, 2024
Industry Headlines
Aurora Receives Expanded Cultivation, Unique Research Licenses for German Facility
The company’s long-standing investment in the region continues with enhanced local production and domestic cultivar research.
July 25, 2024
Industry Headlines
Aurora Marks 1st Medical Cannabis Shipment to New Zealand Market
The Canadian cannabis company launched its premium products aimed at redefining patient care.
May 8, 2024
International
Aurora Cannabis Achieves Australia's TGA GMP Certification
The Canadian-based company’s achievement solidifies its leadership in the Australian market and sets a global standard for quality and compliance
March 20, 2024
Finance
Aurora Cannabis Announces CFO Transition, Completion of Share Consolidation
New chief financial officer Simona King brings deep financial expertise across corporate, operations and international business units.
February 20, 2024
Finance
Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million
The Canada-based global cannabis company announced its financial and operational results for the third quarter of fiscal year 2024, with fiscal 2024 'on track' to be the company's 'strongest to date.'
February 8, 2024
International
Aurora Cannabis Acquires MedReleaf Australia
MedReleaf Australia holds the No. 2 position in medical cannabis within the rapidly growing ~AUD$400 million Australian market.
February 8, 2024
Autoflower Genetics
Research May Explain Gene Responsible for Autoflowering Cannabis
Understanding cannabis’s circadian clock could revolutionize genetics and cultivation practices.
July 5, 2023
Top Stories
Tight on Time: Can Canada’s Licensed Producers Hang On?
Four years after adult-use legalization, cultivators say regulatory policies are exacerbating the challenges they face. Without urgent reform, many businesses might not survive.
March 2, 2023
Industry Headlines
Aurora Announces Fall Product Release Across Adult-Use and Medical Markets
Aurora's medical patients now have expanded access to the company's full portfolio of adult-use cannabis brands.
October 17, 2022
Interviews & Opinion
‘Rounding the Corners:’ Reviewing Canada’s Cannabis Act 4 Years Later
As Canada assesses its cannabis policies four years after adult-use legalization in 2018, licensed producers and retailers across the country say reducing taxes and other changes could transform the program.
October 17, 2022
Previous Page
Page 2 of 5
Next Page